Schiz­o­phre­nia biotech LB Phar­ma­ceu­ti­cals eyes near-term IPO fil­ing — source

New York-based LB Phar­ma­ceu­ti­cals is prepar­ing to file for an ini­tial pub­lic of­fer­ing as in­vestor and phar­ma en­thu­si­asm grows for the neu­ro­science space, a source …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.